Combination of anti-PD-1 antibody with P-GEMOX as a potentially effective immunochemotherapy for advanced natural killer/T cell lymphoma.
Cai J, Liu P, Huang H, Li Y, Ma S, Zhou H, Tian X, Zhang Y, Gao Y, Xia Y, Zhang X, Yang H, Li L, Cai Q.
Cai J, et al. Among authors: zhang x, zhang y.
Signal Transduct Target Ther. 2020 Dec 30;5(1):289. doi: 10.1038/s41392-020-00331-3.
Signal Transduct Target Ther. 2020.
PMID: 33376237
Free PMC article.
Clinical Trial.